Business American hemp production valued at US$824M in 2021: USDA survey Hemp flower was the most popular use of the crop, followed by seed and fibre Nick LabaFebruary 17, 2022
Business Tilray medical cannabis products now available at pharmacies in Malta In December, the country became the first to legalize recreational pot in the EU Natalia Buendia CalvilloFebruary 17, 2022
Business Tetra Bio-Pharma to receive $4.5M loan from Quebec government The funds will go toward developing a treatment for acute respiratory distress syndrome, which can result from Covid-19 Nick LabaFebruary 16, 2022
Business Legal weed sales in Nova Scotia down 5% to $25M Since legalization, the number of weed stores has tripled in the province Kathryn TindaleFebruary 16, 2022
Business Jones Soda completes acquisition to enter Canadian cannabis market The company has also received conditional approval to list on the Canadian Securities Exchange Nick LabaFebruary 16, 2022
Business Annual sales fall 6% to $43.1M for Aleafia The stalwart pot firm is projecting a return to EBITDA-positivity later this year, as it pivots to adult-use sales Nick LabaFebruary 15, 2022
Business Fire & Flower’s Hifyre partners with recruitment firm for hiring spree Job growth in the cannabis sector has averaged over 27% since 2017 Natalia Buendia CalvilloFebruary 15, 2022
Business Brains Bio to start clinical trial on CBD and opioid-use issues The research will take place at the Icahn School of Medicine at Mount Sinai, New York Natalia Buendia CalvilloFebruary 15, 2022
Business Hexo suggests share consolidation to stay on Nasdaq A special shareholder meeting is slated for March 8 Nick LabaFebruary 15, 2022
Business Tetra Bio-Pharma partners with Avicanna to bring cannabinoid medical products to LATAM Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) is teaming up with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to bring Tetra’s products... Natalia Buendia CalvilloFebruary 14, 2022